Discover 1,955 paid clinical trials in Plano, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,955
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
for
Eosinophilic Esophagitis (EoE)
Location: Fort Worth TX, Aurora CO, Atlanta GA, Milwaukee WI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 0 - 6
Code: NCT07112378
Phase 3, Recruiting
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Irving TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06589596
Phase 1, Recruiting
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
for
Cancer
Location: Irving TX, Austin TX, Aurora CO, Atlanta GA, Chicago IL,
Sponsor: MBrace Therapeutics
Sex: All
Age: 18+
Code: NCT06014658
Phase 1, Phase 2, Recruiting
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Fort Worth TX, Houston TX, Plantation FL, Tamarac FL,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07262619
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome,
Location: Dallas TX, Columbus OH, Portland OR
Sponsor: Jennifer Saultz
Sex: All
Age: 18+
Code: NCT03874052
Phase 1, Recruiting
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Irving TX, Austin TX, San Antonio TX, Grand Rapids MI,
Sponsor: Vividion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06804824
Phase 1, Recruiting
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
for
Systemic Lupus Erythematosus (SLE),
Location: Allen TX, Corpus Christi TX, Atlanta GA, Tampa FL,
Sponsor: EMD Serono Research & Development Institute, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07332481
Phase 3, Recruiting
Study of APR-1051 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Irving TX, Houston TX, San Antonio TX, Cleveland OH,
Sponsor: Aprea Therapeutics
Sex: All
Age: 18+
Code: NCT06260514
Phase 1, Recruiting
Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Irving TX, Austin TX, Houston TX, New York NY,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06167317
Phase 1, Recruiting
A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
for
Locally Advanced Unresectable or Metastatic Solid Tumors
Location: Irving TX, Austin TX, San Antonio TX
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Sex: All
Age: 18+
Code: NCT05458219
Phase 1, Recruiting
Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors
for
Solid Tumor
Location: Irving TX, Tyler TX, Houston TX, New Orleans LA,
Sponsor: ImmunoGenesis
Sex: All
Age: 18+
Code: NCT06014502
Phase 1, Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
for
Non-Small Cell Lung Cancer, NSCLC,
Location: Irving TX, Houston TX, Memphis TN, Grand Island NE,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT06162221
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors